Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Follicular 7Lymphoma 7Lymphoma, B-Cell 5Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 3Waldenstrom Macroglobulinemia 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Lymphatic Diseases 2Leukemia, Hairy Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Hodgkin Disease 2Hematologic Diseases 2Sezary Syndrome 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neoplasm, Residual 1Mycosis Fungoides 1Lymphoproliferative Disorders 1Lymphomatoid Papulosis 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Cytokine Release Syndrome 1Burkitt Lymphoma 1

Interventions

fludarabine phosphate 2fludarabine 2Cyclophosphamide 2AP 1903 reagent 2Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Cytokine Release Syndrome × Bendamustine Hydrochloride × Clear all
NCT03696784 2025-12-08

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Active not recruiting
19 enrolled
Lymphoid

Cytokine Release Syndrome, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, B-Cell, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡